Microglia in Ischemic Stroke: Pathogenesis Insights and Therapeutic Challenges

Xinyao Shui,Jingsong Chen,Ziyue Fu,Haoyue Zhu,Hualin Tao,Zhaoyinqian Li

DOI: https://doi.org/10.2147/jir.s461795

IF: 4.5

2024-05-23

Journal of Inflammation Research

Abstract:Xinyao Shui, 1, &ast Jingsong Chen, 2– 4, &ast Ziyue Fu, 1 Haoyue Zhu, 1 Hualin Tao, 2– 4 Zhaoyinqian Li 2– 4 1 Clinical Medical College, Southwest Medical University, Luzhou, People's Republic of China; 2 Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China; 3 Sichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Luzhou, People's Republic of China; 4 Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Luzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhaoyinqian Li, Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, No. 25, Taiping Street, Jiangyang District, Luzhou, Sichuan, 646000, People's Republic of China, Email Ischemic stroke is the most common type of stroke, which is the main cause of death and disability on a global scale. As the primary immune cells in the brain that are crucial for preserving homeostasis of the central nervous system microenvironment, microglia have been found to exhibit dual or even multiple effects at different stages of ischemic stroke. The anti-inflammatory polarization of microglia and release of neurotrophic factors may provide benefits by promoting neurological recovery at the lesion in the early phase after ischemic stroke. However, the pro-inflammatory polarization of microglia and secretion of inflammatory factors in the later phase of injury may exacerbate the ischemic lesion, suggesting the therapeutic potential of modulating the balance of microglial polarization to predispose them to anti-inflammatory transformation in ischemic stroke. Microglia-mediated signaling crosstalk with other cells may also be key to improving functional outcomes following ischemic stroke. Thus, this review provides an overview of microglial functions and responses under physiological and ischemic stroke conditions, including microglial activation, polarization, and interactions with other cells. We focus on approaches that promote anti-inflammatory polarization of microglia, inhibit microglial activation, and enhance beneficial cell-to-cell interactions. These targets may hold promise for the creation of innovative therapeutic strategies. Keywords: microglia, ischemic stroke, phagocytosis, polarization, crosstalk, anti-inflammatory, therapeutic targets Stroke ranks as one of the top causes of death and disability globally. 1 Over the past thirty years, there has been a 70% rise in the global incidence of stroke, a 43% increase in its mortality rate, and at the same time, a 32% increase in disability-adjusted life years. 2 It is predicted that 12 million people will die from stroke by 2030. 3 Stroke is divided into two types. Most strokes are essentially ischemic strokes due to blood clots or lumps blocking blood vessels, while a few strokes are hemorrhagic strokes caused by blood vessel rupture. 4 The latter includes intracerebral hemorrhage and subarachnoid hemorrhage. 5 Stroke has a significant impact on both physical and mental health, disrupting regular daily activities and leading to economic hardship for families and society. Numerous factors have been identified as controllable risk factors for stroke, including hyperlipidemia, alcohol and drug abuse, smoking, unhealthy diet, and diabetes. 6 Even though ischemic stroke has a high incidence rate, the treatment options remain limited. Commonly used treatments include thrombolysis and surgical treatments. Thrombolysis includes intravenous thrombolysis (IVT), 7 arterial thrombolysis (IAT), 8 and bridging therapy (IVT combined with IAT). 9 When it comes to thrombolytic drugs, the FDA only approves thrombolysis with tissue plasminogen activator. The surgical treatment for stroke is mechanical thrombectomy. 10 Further research is being conducted on treatments such as antiplatelet therapy, neuroprotective therapy, stem cell therapy, and rehabilitation therapy, yet their therapeutic effects remain limited. 6 The significance of inflammation in stroke has been emphasized more and more in recent studies. Moreover, the promotion of effective neurogenesis is increasingly being recognized as a crucial therapeutic approach for stroke treatment. The response of microglia post-stroke is intricate and closely linked to the development and prognosis of the stroke. Microglia, functioning as resident immune cells, rapidly activate after an ischemic injury, displaying both pro-inflammatory and anti-inflammatory characteristics and regulating neuroinflammation through polar -Abstract Truncated-

immunology